Work

Phase II study of RAD001 (everolimus) and depot octreotide (sandostatin LAR) in advanced low grade neuroendocrine carcinoma (LGNET)

Year: 2007

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2007.25.18_suppl.4503

Authors: J. C. Yao, A. Phan, D. Z. Chang, R. A. Wolff, C. Jacobs, J. E. Mares, S. Gupta, F. Meric-Bernstam, A. Rashid

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Neuroendocrine Tumor Research Advances

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2221426073

Cites:

Cited by: 23

Related to: 10